Genetic diagnosis of childhood sensorineural hearing loss

Acta Otorrinolaringol Esp (Engl Ed). 2024 Mar-Apr;75(2):83-93. doi: 10.1016/j.otoeng.2023.07.002. Epub 2024 Jan 13.

Abstract

Introduction: Congenital/early-onset sensorineural hearing loss (SNHL) is one of the most common hereditary disorders in our environment. There is increasing awareness of the importance of an etiologic diagnosis, and genetic testing with next-generation sequencing (NGS) has the highest diagnostic yield. Our study shows the genetic results obtained in a cohort of patients with bilateral congenital/early-onset SNHL.

Materials and methods: We included 105 children with bilateral SNHL that received genetic testing between 2019 and 2022. Genetic tests were performed with whole exome sequencing, analyzing genes related to hearing loss (virtual panel with 244 genes).

Results: 48% (50/105) of patients were genetically diagnosed. We identified pathogenic and likely pathogenic variants in 26 different genes, and the most frequently mutated genes were GJB2, USH2A and STRC. 52% (26/50) of variants identified produced non-syndromic hearing loss, 40% (20/50) produced syndromic hearing loss, and the resting 8% (4/50) could produce both non-syndromic and syndromic hearing loss.

Conclusions: Genetic testing plays a vital role in the etiologic diagnosis of bilateral SNHL. Our cohort shows that genetic testing with NGS has a high diagnostic yield and can provide useful information for the clinical workup of patients.

Keywords: Childhood hearing loss; Genetic hearing loss; Hipoacusia genética; Hipoacusia infantil; Hipoacusia neurosensorial; Next-generation sequencing; Secuenciación de nueva generación; Sensorineural hearing loss.

MeSH terms

  • Child
  • Genetic Testing*
  • Hearing Loss, Bilateral / etiology
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Usher Syndromes* / complications

Substances

  • STRC protein, human
  • Intercellular Signaling Peptides and Proteins